OP-3136
OP-3136-101
Phase 1 small_molecule active
Quick answer
OP-3136 for Advanced or Metastatic ER+ HER2- Breast Cancer (mBC) is a Phase 1 program (small_molecule) at Olema Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Olema Pharmaceuticals
- Indication
- Advanced or Metastatic ER+ HER2- Breast Cancer (mBC)
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active